Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 35, Status: Authorised

Mechanical ventilator - Notified body 2696 - 10/01/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2025, 10:00 (CEST) to 21 May 2025, 11:30 (CEST)

EMEA-003641-PIP01-24

EMEA-003640-PIP01-24

Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Veklury, remdesivir, Date of authorisation: 03/07/2020, Revision: 29, Status: Authorised

EMEA-003582-PIP01-24

EMEA-003577-PIP01-24